Cancer Treatment Market Research Reports & Industry Analysis
Cancer is a disease characterized by uncontrolled cell proliferation. Of the more than 100 types of cancer, lung, breast, and colorectal cancer account for nearly half of new cases per year in the United States. Lung cancer, which is highly correlated with cigarette smoking, is responsible for more deaths than any other form of cancer. Cigarette smoking and other environmental factors are associated with the majority of cancers.
With the growing incidence of cancer, a growing and aging world population and significant medical advances, there will continue to be phenomenal growth in the market for cancer diagnosis and treatment products.
Cancer Treatment Industry Research & Market Reports
-
Oropharyngeal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... provides an overview of the Oropharyngeal Cancer (Oncology) pipeline landscape. Oropharyngeal cancer is a disease which malignant cells form in the tissue of oropharynx. Oropharynx is a middle part of the throat which includes the ... Read More
-
Fallopian Tube Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Development, 2022, provides an overview of the Fallopian Tube Cancer (Oncology) pipeline landscape. Fallopian tube cancer is also called tubal cancer. It develops in the fallopian tubes, which serve as a connection between the ovaries ... Read More
-
Basal Cell Carcinoma (Basal Cell Epithelioma) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... (Basal Cell Epithelioma) - Drugs In Development, 2022, provides an overview of the Basal Cell Carcinoma (Basal Cell Epithelioma) (Oncology) pipeline landscape. Basal cell carcinoma is a type of skin cancer which begins in the ... Read More
-
Ureter Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... provides an overview of the Ureter Cancer (Oncology) pipeline landscape. Ureter cancer or ureteral cancer is cancer of the ureter. Symptoms and signs of urethral cancer include bleeding from the urethra or blood in the ... Read More
-
Hairy Cell Leukemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Development, 2022, provides an overview of the Hairy Cell Leukemia (Oncology) pipeline landscape. Hairy cell leukemia is a rare, slow-growing cancer of the blood in which bone marrow makes too many B cells (lymphocytes), a ... Read More
-
Gastric Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... provides an overview of the Gastric Cancer (Oncology) pipeline landscape. Gastric cancer, also called stomach cancer, is a malignant tumor arising from the lining of the stomach. Signs and symptoms of gastric cancer include fatigue, ... Read More
-
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Cancer) - Drugs In Development, 2022, provides an overview of the Adrenocortical Carcinoma (Adrenal Cortex Cancer) (Oncology) pipeline landscape. Adrenal cortex cancer (ACC) is a rare disease. It is caused by a cancerous growth in ... Read More
-
Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size study, By Drug (Monoclonal Antibodies, Immunomodulators, Cancer Vaccines and Oncolytic Therapies and Others }, Service (Target Identification and Validation, Lead screening and Characterization, Cell based Assays), By Cancer Type ( Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Head and Neck Cancer, Ovarian Cancer and Pancreatic Cancer), and Regional Forecasts 2022-2028
... Cancer Type ( Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Head and Neck Cancer, Ovarian Cancer and Pancreatic Cancer), and Regional Forecasts 2022-2028 Global Cancer Immunotherapy Drug Discovery Outsourcing Market is valued approximately ... Read More
-
Head and Neck Cancer Therapeutics: Global Markets
... to help businesses develop growth strategies, assess the market landscape, analyze their positions in the current marketplace, and make informed business decisions regarding head and neck cancer therapeutic drugs. An in-depth analysis of the global ... Read More
-
North America and South & Central America Medical Marijuana Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Dried Form and Extract Form), Application (Pain Management, Tourette’s, Alzheimer’s Disease, Migraines, Depression and Anxiety, Multiple Sclerosis, Cancer, and Others), Distribution Channel (Retail Pharmacy, E-Commerce, and Others), and Regions
... Anxiety, Multiple Sclerosis, Cancer, and Others), Distribution Channel (Retail Pharmacy, E-Commerce, and Others), and Regions The North America and South & Central America medical marijuana market was valued at US$ 6,645.16 million in 2021 and ... Read More
-
Pain Management Devices Market Analysis And Forecast To 2031: By Type (Electrical Stimulators, Radiofrequency Ablation (RFA), Analgesic Infusion Pumps, Neurostimulation), Length (Cancer, Neuropathic Pain, Facial & Migraine, Musculoskeletal Disorder, Trauma), And Region
... management devices market was valued at USD 2.2 billion in 2021 and it is anticipated to grow up to USD 8.0 billion by 2031, at a CAGR of 13.8% during the forecast period. Pain management ... Read More
-
Glycomic Therapeutics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Class (Isolated and Synthetic), Structures [Glycoproteins, Targeting Sialic Acid, Proteoglycans, Targeting Glycosaminoglycans, Glycosylphosphatidylinositol (GPI)-Anchored Proteins & Heparin Based Glycans, Targeting Glycosphingolipids, and Others], Indications (Thrombosis & Chemoprophylaxis, Anaemia, Anti-Adhesive & Anti-Inflammatory, Cataracts, Gaucher’s Disease, MPS-1 & IV, Cancer, Alzheimer’s Disease, Influenza Type A & B, and Others), and Mode of Action [Inhibits Neuraminidase; Inhibits Heparanase and Selectins and Blocks Interactions Between Growth Factors and Heparan Sulfate; Erythropoietin & Enzyme Replacement Therapy (ERT); Tissue Plasminogen Activator; Inhibits Glucosylceramide Synthase; Interleukin 1, 2 & 3; Beta & Gamma Interferons; and Others]
... Others], Indications (Thrombosis & Chemoprophylaxis, Anaemia, Anti-Adhesive & Anti-Inflammatory, Cataracts, Gaucher’s Disease, MPS-1 & IV, Cancer, Alzheimer’s Disease, Influenza Type A & B, and Others), and Mode of Action [Inhibits Neuraminidase; Inhibits Heparanase and Selectins ... Read More
-
NAMPT Inhibitors Market, 2022-2040
... by 2040, the number of cancer cases is projected to reach over 28 million, indicating a cumulative growth of nearly 47%, since 2020. The continuous growth in the number of cancer patients imposes a huge ... Read More
-
FLT3 Inhibitors Market - A Global and Country Analysis: Focus on Commercialized Therapy, Potential Pipeline Product, and Region - Analysis and Forecast, 2022-2032
... expected to reach $2,061.3 million in 2032 from $400.9 million in 2021 at a CAGR of 14.88% during the forecast period 2022-2032. The global FLT3 inhibitors market growth is expected to be driven by the ... Read More
-
Medical Marijuana Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Dried Form and Extract Form), Application (Pain Management, Tourette Syndrome, Alzheimer’s Disease, Migraines, Depression and Anxiety, Multiple Sclerosis, Cancer, and Others), Distribution Channel (Retail Pharmacy, E-Commerce, and Others), and Geography
... Distribution Channel (Retail Pharmacy, E-Commerce, and Others), and Geography The medical marijuana market was valued at US$ 11,706.50 million in 2021 and is likely to reach value of US$ 40,027.59 million by 2028; it is ... Read More
-
Global Intraoperative Radiation Therapy Market, By Technology (Intraoperative Brachytherapy, Electron Intraoperative Radiation Therapy And Others); By Product and Service (Products (Applicators & Afterloaders, Treatment Planning Systems) And Services), By Application (Breast Cancer, Brain Tumor, Lung Cancer, Gastrointestinal Cancer, Endometrial & Cervical Cancer And Others), By Region (North America, Europe, The Asia Pacific, Latin America, The Middle East); Trend Analysis, Competitive Market Share & Forecast, 2018-2028
... Cancer, Gastrointestinal Cancer, Endometrial & Cervical Cancer And Others), By Region (North America, Europe, The Asia Pacific, Latin America, The Middle East); Trend Analysis, Competitive Market Share & Forecast, 2018-2028 Global Intraoperative Radiation Therapy Market ... Read More
-
Pain Management Devices Market, By Type (Neuromodulation & Neurostimulation Devices, Analgesic Infusion Pumps, and Ablation Devices), By Application (Neuropathic Pain, Cancer Pain, Facial & Migraine Pain, Musculoskeletal Pain, and Others), By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
... Asia-Pacific, Middle East and Africa, and South America) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Pain management is a branch of medical science that reduces the pain of patients with chronic pain. ... Read More
-
Colorectal Procedure Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Endoscope, Electrosurgery, Handheld Devices & Visual Systems, Sealing & Stapling Devices, Ligation Clips and Dilators and Speculas, Cutter & Shears, Accessories, and Others), Surgery Type [Right Hemicolectomy, Left Hemicolectomy, Subtotal Colectomy, Low Anterior Resection, Abdomino-Perineal Resection, and Others (Including Endoscopic Surgery etc.)], End User (Hospitals & Clinics, Surgery Centers, and Others), and Indication (Colon Polyps, Crohn's Disease, Colorectal Cancer, Colitis, Irritable Bowel Syndrome, and Other Indications)
... and Others), Surgery Type [Right Hemicolectomy, Left Hemicolectomy, Subtotal Colectomy, Low Anterior Resection, Abdomino-Perineal Resection, and Others (Including Endoscopic Surgery etc.)], End User (Hospitals & Clinics, Surgery Centers, and Others), and Indication (Colon Polyps, Crohn's ... Read More
-
Embolotherapy Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Embolic Agent and Support Device), Disease Indication (Cancer, Peripheral Vascular Disease, Neurological Disease, Urological & Nephrological Disorder, Gastrointestinal Disorder, and Other), Procedure (Transcatheter Arterial Embolization (TAE), Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT), and Transarterial Chemoembolization (TACE)), and End User (Hospital & Clinic, Ambulatory Surgery Center, and Other End User)
... (Transcatheter Arterial Embolization (TAE), Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT), and Transarterial Chemoembolization (TACE)), and End User (Hospital & Clinic, Ambulatory Surgery Center, and Other End User) The embolotherapy market is expected to ... Read More
-
Immunotherapy Drugs Market, By Product (Monoclonal Antibodies, Immuno Modulators, Car T-Cell Therapy, Others), By Applications (Cancer, Autoimmune & Inflammatory Diseases, Others), and By Geography (Europe, APAC, North America, Latin America, And Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
... Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Immunotherapy is a cancer treatment that enhances the immune system's ability to fight cancer. Immunotherapy is preferable than the old technique as it helps treat a ... Read More
-
Immuno-Oncology Assay Market Analysis and Forecast to 2031: By Product & Service (Consumables, Instruments, Software & Services), Technology (PCR, Immunoassay, NGS, ISH, Flow Cytometry), Indication (Lung Cancer, Breast Cancer, Colorectal Cancer, Bladder Cancer, Melanoma, Others), Application (Research Applications, Clinical Diagnostics), and Region
... Application (Research Applications, Clinical Diagnostics), and Region The global immune-oncology assay market was valued at USD 4.2 billion in 2021 and it is anticipated to grow further up to USD 14.1 billion by 2031, at ... Read More
-
Pet Cancer Therapeutics Market Size By Therapy (Chemotherapy, Immunotherapy, Targeted Therapy, Combination Therapy), By Route of Administration (Oral, Injection), By Species (Dogs, Cats), By Application (Lymphoma, Mast Cell Cancer, Melanoma, Mammary and Squamous Cell Cancer), Industry Analysis Report, Regional Outlook, Growth Potential, COVID-19 Impact Analysis, Price Trends, Competitive Market Share & Forecast, 2022 - 2030
... Industry Analysis Report, Regional Outlook, Growth Potential, COVID-19 Impact Analysis, Price Trends, Competitive Market Share & Forecast, 2022 - 2030 The pet cancer therapeutics market is set to grow enormously through 2030 owing to rising ... Read More
-
Oncology Drugs Market, by Drug Type (Cytotoxic Drugs (Alkylating Agents, Antimetabolites, and Others), Targeted Drugs (Monoclonal Antibodies, Tyrosine Kinase Inhibitors, and Others), and Hormonal Drugs (Ovarian Function Blockers, Estrogen Production Blockers, and Estrogen’s Effect Blockers (Selective Estrogen Receptor Modulators (SERMs) and Others)), by Cancer Type (Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Blood Cancer, Bladder Cancer, and Others), by Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... (Selective Estrogen Receptor Modulators (SERMs) and Others)), by Cancer Type (Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Blood Cancer, Bladder Cancer, and Others), by Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, and Online Pharmacies), and ... Read More
-
Radiotherapy Market by Type (Product, Service), Technology (LINAC, Stereotactic LINAC, Particle Therapy, Cobalt-60 Teletherapy), Procedure (IMRT, IGRT, 3D-CRT, LDR, HDR), Application (Prostate, Breast, Lung), End User (Hospital) - Global Forecasts to 2027
... market is valued at USD 6.3 billion in 2022 and is expected to reach USD 8.1 billion by 2027, at a CAGR of 5.1% during the forecast period. Technological advancements in radiotherapy and the rising ... Read More
-
Pancreatic Cancer - Market Insight, Epidemiology And Market Forecast - 2032
... well as the pancreatic cancer market trends in the United States, EU-5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan. The pancreatic cancer market report provides current treatment practices, emerging drugs, and market ... Read More
Research Assistance
